Operating Income (Loss) in USD of Beta Bionics, Inc. from 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Beta Bionics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2023 to Q3 2025.
  • Beta Bionics, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$17M, a 55.3% decline year-over-year.
  • Beta Bionics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$68.6M.
  • Beta Bionics, Inc. annual Operating Income (Loss) for 2024 was -$45.3M, a 26.2% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Beta Bionics, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$68.6M -$17M -$6.07M -55.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-28
Q2 2025 -$62.5M -$19.9M -$8.09M -68.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-29
Q1 2025 -$54.4M -$18.6M -$9.19M -97.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 -$45.3M -$13M Oct 1, 2024 Dec 31, 2024 10-K/A 2025-03-28
Q3 2024 -$11M Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-28
Q2 2024 -$11.8M Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-29
Q1 2024 -$9.45M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06

Beta Bionics, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$45.3M -$9.4M -26.2% Jan 1, 2024 Dec 31, 2024 10-K/A 2025-03-28
2023 -$35.9M Jan 1, 2023 Dec 31, 2023 10-K/A 2025-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.